Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
73
XDNA.TO Quote, Financials, Valuation and Earnings
Last price:
$38.20
Seasonality move
:
-3.83%
Day range:
$37.78 - $37.78
52-week range:
$27.00 - $39.90
Dividend yield:
0.45%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
350
Avg. volume:
325
1-year change:
12.92%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XDNA.TO
iShares Genomics Immunology and Healthcare Idx ETF
|
-- | -- | -- | -- | -- |
|
FBT.TO
First Trust NYSE Arca Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
FHH.TO
First Trust AlphaDEX™ US Hlth Care Sector Idx ETF
|
-- | -- | -- | -- | -- |
|
MEDX.TO
Global X Eq Wght Global Healthcare idx ETF Cl A
|
-- | -- | -- | -- | -- |
|
ZHU.TO
BMO Equal Weight US Health Care Indx ETF
|
-- | -- | -- | -- | -- |
|
ZUH.TO
BMO Equal Weight US Health Care Hgd to CAD Idx ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XDNA.TO
iShares Genomics Immunology and Healthcare Idx ETF
|
$38.20 | -- | -- | -- | $0.16 | 0.45% | -- |
|
FBT.TO
First Trust NYSE Arca Biotechnology ETF
|
$37.09 | -- | -- | -- | $0.00 | 0% | -- |
|
FHH.TO
First Trust AlphaDEX™ US Hlth Care Sector Idx ETF
|
$42.66 | -- | -- | -- | $0.01 | 0.07% | -- |
|
MEDX.TO
Global X Eq Wght Global Healthcare idx ETF Cl A
|
$22.39 | -- | -- | -- | $0.09 | 0% | -- |
|
ZHU.TO
BMO Equal Weight US Health Care Indx ETF
|
$44.80 | -- | -- | -- | $0.25 | 0.56% | -- |
|
ZUH.TO
BMO Equal Weight US Health Care Hgd to CAD Idx ETF
|
$70.65 | -- | -- | -- | $0.49 | 0.69% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XDNA.TO
iShares Genomics Immunology and Healthcare Idx ETF
|
-- | 1.166 | -- | -- |
|
FBT.TO
First Trust NYSE Arca Biotechnology ETF
|
-- | 1.195 | -- | -- |
|
FHH.TO
First Trust AlphaDEX™ US Hlth Care Sector Idx ETF
|
-- | 1.354 | -- | -- |
|
MEDX.TO
Global X Eq Wght Global Healthcare idx ETF Cl A
|
-- | 0.000 | -- | -- |
|
ZHU.TO
BMO Equal Weight US Health Care Indx ETF
|
-- | 1.183 | -- | -- |
|
ZUH.TO
BMO Equal Weight US Health Care Hgd to CAD Idx ETF
|
-- | 1.194 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XDNA.TO
iShares Genomics Immunology and Healthcare Idx ETF
|
-- | -- | -- | -- | -- | -- |
|
FBT.TO
First Trust NYSE Arca Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
FHH.TO
First Trust AlphaDEX™ US Hlth Care Sector Idx ETF
|
-- | -- | -- | -- | -- | -- |
|
MEDX.TO
Global X Eq Wght Global Healthcare idx ETF Cl A
|
-- | -- | -- | -- | -- | -- |
|
ZHU.TO
BMO Equal Weight US Health Care Indx ETF
|
-- | -- | -- | -- | -- | -- |
|
ZUH.TO
BMO Equal Weight US Health Care Hgd to CAD Idx ETF
|
-- | -- | -- | -- | -- | -- |
iShares Genomics Immunology and Healthcare Idx ETF vs. Competitors
-
Which has Higher Returns XDNA.TO or FBT.TO?
First Trust NYSE Arca Biotechnology ETF has a net margin of -- compared to iShares Genomics Immunology and Healthcare Idx ETF's net margin of --. iShares Genomics Immunology and Healthcare Idx ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF-- -- -- FBT.TOFirst Trust NYSE Arca Biotechnology ETF-- -- -- -
What do Analysts Say About XDNA.TO or FBT.TO?
iShares Genomics Immunology and Healthcare Idx ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Genomics Immunology and Healthcare Idx ETF has higher upside potential than First Trust NYSE Arca Biotechnology ETF, analysts believe iShares Genomics Immunology and Healthcare Idx ETF is more attractive than First Trust NYSE Arca Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF0 0 0 FBT.TOFirst Trust NYSE Arca Biotechnology ETF0 0 0 -
Is XDNA.TO or FBT.TO More Risky?
iShares Genomics Immunology and Healthcare Idx ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology ETF has a beta of 0.603, suggesting its less volatile than the S&P 500 by 39.708%.
-
Which is a Better Dividend Stock XDNA.TO or FBT.TO?
iShares Genomics Immunology and Healthcare Idx ETF has a quarterly dividend of $0.16 per share corresponding to a yield of 0.45%. First Trust NYSE Arca Biotechnology ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iShares Genomics Immunology and Healthcare Idx ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XDNA.TO or FBT.TO?
iShares Genomics Immunology and Healthcare Idx ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology ETF quarterly revenues of --. iShares Genomics Immunology and Healthcare Idx ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology ETF's net income of --. Notably, iShares Genomics Immunology and Healthcare Idx ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Genomics Immunology and Healthcare Idx ETF is -- versus -- for First Trust NYSE Arca Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF-- -- -- -- FBT.TOFirst Trust NYSE Arca Biotechnology ETF-- -- -- --
-
Which has Higher Returns XDNA.TO or FHH.TO?
First Trust AlphaDEX™ US Hlth Care Sector Idx ETF has a net margin of -- compared to iShares Genomics Immunology and Healthcare Idx ETF's net margin of --. iShares Genomics Immunology and Healthcare Idx ETF's return on equity of -- beat First Trust AlphaDEX™ US Hlth Care Sector Idx ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF-- -- -- FHH.TOFirst Trust AlphaDEX™ US Hlth Care Sector Idx ETF-- -- -- -
What do Analysts Say About XDNA.TO or FHH.TO?
iShares Genomics Immunology and Healthcare Idx ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust AlphaDEX™ US Hlth Care Sector Idx ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Genomics Immunology and Healthcare Idx ETF has higher upside potential than First Trust AlphaDEX™ US Hlth Care Sector Idx ETF, analysts believe iShares Genomics Immunology and Healthcare Idx ETF is more attractive than First Trust AlphaDEX™ US Hlth Care Sector Idx ETF.
Company Buy Ratings Hold Ratings Sell Ratings XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF0 0 0 FHH.TOFirst Trust AlphaDEX™ US Hlth Care Sector Idx ETF0 0 0 -
Is XDNA.TO or FHH.TO More Risky?
iShares Genomics Immunology and Healthcare Idx ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison First Trust AlphaDEX™ US Hlth Care Sector Idx ETF has a beta of 0.699, suggesting its less volatile than the S&P 500 by 30.053%.
-
Which is a Better Dividend Stock XDNA.TO or FHH.TO?
iShares Genomics Immunology and Healthcare Idx ETF has a quarterly dividend of $0.16 per share corresponding to a yield of 0.45%. First Trust AlphaDEX™ US Hlth Care Sector Idx ETF offers a yield of 0.07% to investors and pays a quarterly dividend of $0.01 per share. iShares Genomics Immunology and Healthcare Idx ETF pays -- of its earnings as a dividend. First Trust AlphaDEX™ US Hlth Care Sector Idx ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XDNA.TO or FHH.TO?
iShares Genomics Immunology and Healthcare Idx ETF quarterly revenues are --, which are smaller than First Trust AlphaDEX™ US Hlth Care Sector Idx ETF quarterly revenues of --. iShares Genomics Immunology and Healthcare Idx ETF's net income of -- is lower than First Trust AlphaDEX™ US Hlth Care Sector Idx ETF's net income of --. Notably, iShares Genomics Immunology and Healthcare Idx ETF's price-to-earnings ratio is -- while First Trust AlphaDEX™ US Hlth Care Sector Idx ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Genomics Immunology and Healthcare Idx ETF is -- versus -- for First Trust AlphaDEX™ US Hlth Care Sector Idx ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF-- -- -- -- FHH.TOFirst Trust AlphaDEX™ US Hlth Care Sector Idx ETF-- -- -- --
-
Which has Higher Returns XDNA.TO or MEDX.TO?
Global X Eq Wght Global Healthcare idx ETF Cl A has a net margin of -- compared to iShares Genomics Immunology and Healthcare Idx ETF's net margin of --. iShares Genomics Immunology and Healthcare Idx ETF's return on equity of -- beat Global X Eq Wght Global Healthcare idx ETF Cl A's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF-- -- -- MEDX.TOGlobal X Eq Wght Global Healthcare idx ETF Cl A-- -- -- -
What do Analysts Say About XDNA.TO or MEDX.TO?
iShares Genomics Immunology and Healthcare Idx ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Eq Wght Global Healthcare idx ETF Cl A has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Genomics Immunology and Healthcare Idx ETF has higher upside potential than Global X Eq Wght Global Healthcare idx ETF Cl A, analysts believe iShares Genomics Immunology and Healthcare Idx ETF is more attractive than Global X Eq Wght Global Healthcare idx ETF Cl A.
Company Buy Ratings Hold Ratings Sell Ratings XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF0 0 0 MEDX.TOGlobal X Eq Wght Global Healthcare idx ETF Cl A0 0 0 -
Is XDNA.TO or MEDX.TO More Risky?
iShares Genomics Immunology and Healthcare Idx ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Eq Wght Global Healthcare idx ETF Cl A has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock XDNA.TO or MEDX.TO?
iShares Genomics Immunology and Healthcare Idx ETF has a quarterly dividend of $0.16 per share corresponding to a yield of 0.45%. Global X Eq Wght Global Healthcare idx ETF Cl A offers a yield of 0% to investors and pays a quarterly dividend of $0.09 per share. iShares Genomics Immunology and Healthcare Idx ETF pays -- of its earnings as a dividend. Global X Eq Wght Global Healthcare idx ETF Cl A pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XDNA.TO or MEDX.TO?
iShares Genomics Immunology and Healthcare Idx ETF quarterly revenues are --, which are smaller than Global X Eq Wght Global Healthcare idx ETF Cl A quarterly revenues of --. iShares Genomics Immunology and Healthcare Idx ETF's net income of -- is lower than Global X Eq Wght Global Healthcare idx ETF Cl A's net income of --. Notably, iShares Genomics Immunology and Healthcare Idx ETF's price-to-earnings ratio is -- while Global X Eq Wght Global Healthcare idx ETF Cl A's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Genomics Immunology and Healthcare Idx ETF is -- versus -- for Global X Eq Wght Global Healthcare idx ETF Cl A. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF-- -- -- -- MEDX.TOGlobal X Eq Wght Global Healthcare idx ETF Cl A-- -- -- --
-
Which has Higher Returns XDNA.TO or ZHU.TO?
BMO Equal Weight US Health Care Indx ETF has a net margin of -- compared to iShares Genomics Immunology and Healthcare Idx ETF's net margin of --. iShares Genomics Immunology and Healthcare Idx ETF's return on equity of -- beat BMO Equal Weight US Health Care Indx ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF-- -- -- ZHU.TOBMO Equal Weight US Health Care Indx ETF-- -- -- -
What do Analysts Say About XDNA.TO or ZHU.TO?
iShares Genomics Immunology and Healthcare Idx ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand BMO Equal Weight US Health Care Indx ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Genomics Immunology and Healthcare Idx ETF has higher upside potential than BMO Equal Weight US Health Care Indx ETF, analysts believe iShares Genomics Immunology and Healthcare Idx ETF is more attractive than BMO Equal Weight US Health Care Indx ETF.
Company Buy Ratings Hold Ratings Sell Ratings XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF0 0 0 ZHU.TOBMO Equal Weight US Health Care Indx ETF0 0 0 -
Is XDNA.TO or ZHU.TO More Risky?
iShares Genomics Immunology and Healthcare Idx ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison BMO Equal Weight US Health Care Indx ETF has a beta of 0.698, suggesting its less volatile than the S&P 500 by 30.154%.
-
Which is a Better Dividend Stock XDNA.TO or ZHU.TO?
iShares Genomics Immunology and Healthcare Idx ETF has a quarterly dividend of $0.16 per share corresponding to a yield of 0.45%. BMO Equal Weight US Health Care Indx ETF offers a yield of 0.56% to investors and pays a quarterly dividend of $0.25 per share. iShares Genomics Immunology and Healthcare Idx ETF pays -- of its earnings as a dividend. BMO Equal Weight US Health Care Indx ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XDNA.TO or ZHU.TO?
iShares Genomics Immunology and Healthcare Idx ETF quarterly revenues are --, which are smaller than BMO Equal Weight US Health Care Indx ETF quarterly revenues of --. iShares Genomics Immunology and Healthcare Idx ETF's net income of -- is lower than BMO Equal Weight US Health Care Indx ETF's net income of --. Notably, iShares Genomics Immunology and Healthcare Idx ETF's price-to-earnings ratio is -- while BMO Equal Weight US Health Care Indx ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Genomics Immunology and Healthcare Idx ETF is -- versus -- for BMO Equal Weight US Health Care Indx ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF-- -- -- -- ZHU.TOBMO Equal Weight US Health Care Indx ETF-- -- -- --
-
Which has Higher Returns XDNA.TO or ZUH.TO?
BMO Equal Weight US Health Care Hgd to CAD Idx ETF has a net margin of -- compared to iShares Genomics Immunology and Healthcare Idx ETF's net margin of --. iShares Genomics Immunology and Healthcare Idx ETF's return on equity of -- beat BMO Equal Weight US Health Care Hgd to CAD Idx ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF-- -- -- ZUH.TOBMO Equal Weight US Health Care Hgd to CAD Idx ETF-- -- -- -
What do Analysts Say About XDNA.TO or ZUH.TO?
iShares Genomics Immunology and Healthcare Idx ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand BMO Equal Weight US Health Care Hgd to CAD Idx ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Genomics Immunology and Healthcare Idx ETF has higher upside potential than BMO Equal Weight US Health Care Hgd to CAD Idx ETF, analysts believe iShares Genomics Immunology and Healthcare Idx ETF is more attractive than BMO Equal Weight US Health Care Hgd to CAD Idx ETF.
Company Buy Ratings Hold Ratings Sell Ratings XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF0 0 0 ZUH.TOBMO Equal Weight US Health Care Hgd to CAD Idx ETF0 0 0 -
Is XDNA.TO or ZUH.TO More Risky?
iShares Genomics Immunology and Healthcare Idx ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison BMO Equal Weight US Health Care Hgd to CAD Idx ETF has a beta of 0.965, suggesting its less volatile than the S&P 500 by 3.481%.
-
Which is a Better Dividend Stock XDNA.TO or ZUH.TO?
iShares Genomics Immunology and Healthcare Idx ETF has a quarterly dividend of $0.16 per share corresponding to a yield of 0.45%. BMO Equal Weight US Health Care Hgd to CAD Idx ETF offers a yield of 0.69% to investors and pays a quarterly dividend of $0.49 per share. iShares Genomics Immunology and Healthcare Idx ETF pays -- of its earnings as a dividend. BMO Equal Weight US Health Care Hgd to CAD Idx ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XDNA.TO or ZUH.TO?
iShares Genomics Immunology and Healthcare Idx ETF quarterly revenues are --, which are smaller than BMO Equal Weight US Health Care Hgd to CAD Idx ETF quarterly revenues of --. iShares Genomics Immunology and Healthcare Idx ETF's net income of -- is lower than BMO Equal Weight US Health Care Hgd to CAD Idx ETF's net income of --. Notably, iShares Genomics Immunology and Healthcare Idx ETF's price-to-earnings ratio is -- while BMO Equal Weight US Health Care Hgd to CAD Idx ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Genomics Immunology and Healthcare Idx ETF is -- versus -- for BMO Equal Weight US Health Care Hgd to CAD Idx ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF-- -- -- -- ZUH.TOBMO Equal Weight US Health Care Hgd to CAD Idx ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
